Money

Valneva says UK rollout of COVID-19 vaccine could start in July-Sept – report



© Reuters. FILE PHOTO: A woman holds a medical syringe and a small bottle labelled “Coronavirus COVID-19 Vaccine

LONDON (Reuters) – French drugmaker Valneva hopes its COVID-19 vaccine can start to be used in Britain between July and September, the company’s chief executive was quoted as saying.

Valneva has agreed to provide Britain with 60 million doses of its vaccine, compared with 100 million doses of the shot from AstraZeneca and Oxford University. It is expected to need a two-dose regimen.

“We are days away from starting the commercial manufacturing,” Thomas Lingelbach told The Mail on Sunday newspaper.

“We cannot release it without regulatory approval so we’re in a little bit of a Catch-22 situation and there are certainly scenarios that we are currently discussing with the regulators,” he added. “But we have already signed up to give priority to the UK and this is something we’re currently working on.”

Valneva said in September that its vaccine would be available for use in Britain in the second half of 2021.

Britain has launched Europe’s fastest rollout of COVID-19 vaccines and its foreign minister Dominic Raab said on Sunday the government hoped to ease some lockdown restrictions in March.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

READ  Exclusive: FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft case - sources

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.